Priorities for CMV vaccine development

A multidisciplinary meeting addressed priorities related to development of vaccines against cytomegalovirus (CMV), the cause of congenital CMV (cCMV) disease and of serious disease in the immunocompromised. Participants discussed optimal uses of a CMV vaccine, aspects of clinical study design, and t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine
Main Authors: Krause, Philip R., Bialek, Stephanie R., Boppana, Suresh B., Griffiths, Paul D., Laughlin, Catherine A., Ljungman, Per, Mocarski, Edward S., Pass, Robert F., Read, Jennifer S., Schleiss, Mark R., Plotkin, Stanley A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623576/
https://ncbi.nlm.nih.gov/pubmed/24129123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.09.042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados